Different effects of high molecular weight sodium hyaluronate and NSAID on the progression of the cartilage degeneration in rabbit OA model

Osteoarthritis and Cartilage

Volumn 15, Issue 5, 2007, Pages 543-549

  Mihara, M ^a   Higo, S ^a   Uchiyama, Y ^a   Tanabe, K ^a   Saito, K ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Articular cartilage degradation; Hyaluronate; Meniscectomy; NSAIDs

Indexed keywords

HYALURONIC ACID; LOXOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; SUVENYL; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MODEL; DRUG EFFICACY; HINDLIMB; HISTOPATHOLOGY; KNEE INJURY; KNEE OSTEOARTHRITIS; MALE; MENISCECTOMY; MOLECULAR WEIGHT; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RABBIT; WEIGHT BEARING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; HINDLIMB; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; OSTEOARTHRITIS; PAIN; RABBITS; WEIGHT-BEARING;

EID: 34247641689     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.11.001     Document Type: Article

References (28)

1. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 43 (2000) 1905-1915
2. Huskisson E.C., Berry H., Gishen P., Jubb R.W., and Whitehead J. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK study group. Longitudinal investigation of nonsteroidal antiinflammatory drugs in knee osteoarthritis. J Rheumatol 22 (1995) 1941-1946
3. Rashad S., Revell P., Hemingway A., Low F., Rainsford K., and Walker F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 2 (1989) 519-522
4. Dougados M., Gueguen A., Nguyen M., Berdah L., Lequesne M., Mazieres B., et al. Radiological progression of hip osteoarthritis: definition, risk factors and correlations with clinical status. Ann Rheum Dis 55 (1996) 356-362
5. Reijman M., Bierma-Zeinstra S.M., Pols H.A., Koes B.W., Stricker B.H., and Hazes J.M. Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study. Arthritis Rheum 52 (2005) 3137-3142
6. Petrella R.J., DiSilvestro M.D., and Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee. A randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 162 (2002) 292-298
7. Dougados M., Nguyen M., Listrat V., and Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1 (1993) 97-103
8. Salk R.S., Chang T.J., D'Costa W.F., Soomekh D.J., and Grogan K.A. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 88 (2006) 295-302
9. Kobayashi Y., Okamoto A., and Nishinari K. Viscoelasticity of hyaluronic acid with different molecular weights. Biorheology 31 (1994) 235-244
10. Sugimoto M., Kojima T., Asami M., Iizuka Y., and Matsuda K. Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrug. Biochem Pharmacol 42 (1991) 2363-2368
11. Kikuchi T., Yamada H., and Shinmei M. Effect of high molecular weight hyaluronan on articular cartilage degeneration in a rabbit model of osteoarthritis. Osteoarthritis Cartilage 4 (1996) 99-110
12. Noguchi M., Kimoto A., Gierse J.K., Walker M.C., Zweifel B.S., Nozaki K., et al. Enzymologic and pharmacologic profile of loxoprofen sodium and its metabolites. Biol Pharm Bull 28 (2005) 2075-2079
13. Pomonis J.D., Boulet J.M., Gottshall S.L., Phillips S., Sellers R., Bunton T., et al. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 114 (2005) 339-346
14. McDougall J.J., Watkins L., and Li Z. Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis. Pain 123 (2006) 98-105
15. Bley K.R., Bhattacharya A., Daniels D.V., Gever J., Jahangir A., O'Yang C., et al. RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists. Br J Pharmacol 147 (2006) 335-345
16. Konttinen Y.T., Saari H., and Nordstrom D.C. Effect of interleukin-1 on hyaluronate synthesis by synovial fibroblastic cells. Clin Rheumatol 10 (1991) 151-154
17. Shimizu M., Yasuda T., Nakagawa T., Yamashita E., Julovi S.M., Hiramitsu T., et al. Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. J Rheumatol 30 (2003) 1164-1172
18. Takahashi K., Goomer R.S., Harwood F., Kubo T., Hirasawa Y., and Amiel D. The effect of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta (IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage 7 (1999) 182-190
19. Tanaka M., Masuko-Hongo K., Kato T., Nishioka K., and Nakamura H. Suppressive effects of hyaluronan on MMP-1 and RANTES production from chondrocytes. Rheumatol Int 26 (2006) 185-190
20. Kikuchi T., and Shimmei M. Effects of hyaluronan on proteoglycan metabolism of rabbit articular chondrocytes in culture. Jpn J Rheumatol 3 (1994) 207-215
21. Kawasaki K., Ochi M., Uchio Y., Adachi N., and Matsusaki M. Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 179 (1999) 142-148
22. Smith M.M., and Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblast is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 7 (1987) 113-122
23. Lisignoli G., Grassi F., Zini N., Toneguzzi S., Piacentini A., Guidolin D., et al. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum 44 (2001) 1800-1807
24. Yasui T., Akatsuka M., Tobetto K., Hayaishi M., and Ando T. The effect of hyaluronan on interleukin-1 alpha-induced prostaglandin E2 production in human osteoarthritic synovial cells. Agents Actions 37 (1992) 155-156
25. Comer J.S., Kincaid S.A., Baird A.N., Kammermann J.R., Hanson Jr. R.R., and Ogawa Y. Immunolocalization of stromelysin, tumor necrosis factor (TNF) alpha, and TNF receptors in atrophied canine articular cartilage treated with hyaluronic acid and transforming growth factor beta. Am J Vet Res 57 (1996) 1488-1496
26. Takahashi K., Hashimoto S., Kubo T., Hirasawa Y., Lotz M., and Amiel D. Hyaluronan suppressed nitric oxide production in the meniscus and synovium of rabbit osteoarthritis model. J Orthop Res 19 (2001) 500-503
27. Collier S., and Ghosh P. Comparison of the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on proteoglycan synthesis by articular cartilage explant and chondrocyte monolayer culture. Biochem Pharmacol 41 (1991) 1375-1384
28. Bjelle A., and Eronen I. The in vitro effect of six NSAIDs on the glycosaminoglycan metabolism of rabbit chondrocytes. Clin Exp Rheumatol 9 (1991) 369-374